日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of assigned care providers on involvement, information, and emotional support to cancer patients

指定护理人员对癌症患者的参与度、信息获取和情感支持的影响

Fohlin, Helena; Stiller, Helena Tufvesson; Uppugunduri, Srinivas; Schmitt-Egenolf, Marcus

Sweden surpasses the UNAIDS 95-95-95 target: estimating HIV-1 incidence, 2003 to 2022

瑞典超额完成联合国艾滋病规划署95-95-95目标:2003年至2022年HIV-1感染率估算

Lundgren, Erik; Locke, Macauley; Romero-Severson, Ethan; Dimitrijevic, Mira; Axelsson, Maria; Andersson, Emmi; Carlander, Christina; Brännström, Johanna; Norrgren, Hans; Mansson, Fredrik; Elvstam, Olof; Gisslén, Magnus; Fohlin, Lisa; Sönnerborg, Anders; Albert, Jan; Leitner, Thomas

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up

乳腺癌激素受体水平与辅助他莫昔芬治疗获益:一项随机试验的长期随访研究

Fohlin, Helena; Nordenskjöld, Anna; Rosell, Johan; Fernö, Mårten; Fornander, Tommy; Rydén, Lisa; Skoog, Lambert; Nordenskjöld, Bo; Stål, Olle

Patient reported experiences of Swedish patients being investigated for cancer during the Covid-19 pandemic

瑞典患者在新冠疫情期间接受癌症检查的经历报告

Tufvesson Stiller, Helena; Schmitt-Egenolf, Marcus; Fohlin, Helena; Uppugunduri, Srinivas

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

采用多柔比星、博来霉素、长春碱、达卡巴嗪联合有限野放射疗法治疗I-IIA期霍奇金淋巴瘤,可降低但未完全消除长期并发症发生率。

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt; Goldkuhl, Christina; Palma, Marzia; Åkesson, Lisa; Glimelius, Ingrid; Molin, Daniel

RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer

RAB6C是雌激素受体阳性/孕激素受体阴性乳腺癌的独立预后因素

Fohlin, Helena; Bekkhus, Tove; Sandström, Josefine; Fornander, Tommy; Nordenskjöld, Bo; Carstensen, John; Stål, Olle

Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer

RAB6C低表达是雌激素受体阳性/孕激素受体阴性乳腺癌患者服用他莫昔芬获益的预测因子

Fohlin, Helena; Bekkhus, Tove; Sandström, Josefine; Fornander, Tommy; Nordenskjöld, Bo; Carstensen, John; Stål, Olle

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

孕激素受体阳性是雌激素受体阳性乳腺癌患者接受辅助他莫昔芬治疗长期获益的预测指标。

Nordenskjöld, Anna; Fohlin, Helena; Fornander, Tommy; Löfdahl, Britta; Skoog, Lambert; Stål, Olle

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

蛋白质组学分析表明 CAPS 是雌激素受体阳性乳腺癌他莫昔芬耐药性的潜在预测标志物

Henrik J Johansson, Betzabe C Sanchez, Jenny Forshed, Olle Stål, Helena Fohlin, Rolf Lewensohn, Per Hall, Jonas Bergh, Janne Lehtiö, Barbro K Linderholm

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer

戈舍瑞林辅助治疗对绝经前早期乳腺癌患者的长期疗效

Hackshaw, Allan; Baum, Michael; Fornander, Tommy; Nordenskjold, Bo; Nicolucci, Antonio; Monson, Kathryn; Forsyth, Sharon; Reczko, Krystyna; Johansson, Ulla; Fohlin, Helena; Valentini, Miriam; Sainsbury, Richard